| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/02/2002 | US20020051982 Novel BLR molecules affecting antibiotic susceptibility |
| 05/02/2002 | US20020051980 Methods for modulating the activation of a lymphocyte expressed G protein coupled receptor involved in cell proliferation, autoimmunity and inflammation |
| 05/02/2002 | US20020051977 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 05/02/2002 | US20020051976 Methods and compositions for polypeptide engineering |
| 05/02/2002 | US20020051972 Polypeptide; for use in diagnosis and treatment of nervous system disorders, leukemia and cancer; antitumor agents |
| 05/02/2002 | US20020051969 Modulatory polypeptide; for use in the treatment of bone disorders |
| 05/02/2002 | US20020051968 Viral nucleotide sequences for use in the diagnosis and detection of viral diseases; for use in generation of vaccines |
| 05/02/2002 | US20020051967 Retrovirus; for use as a tool in the diagnosis and prevention of viaral diseases |
| 05/02/2002 | US20020051965 Modifications of the VEGF receptor-2 protein and methods of use |
| 05/02/2002 | US20020051819 Hexapeptide mixture with antimicrobial activity against Burkholderia cepacia and at least one carrier, effeactive for prevention of growth of Burkholderia cepacia for industrial, pharmeceutical, household and personal care use |
| 05/02/2002 | US20020051791 Administering anthrax toxin lethal factor (LF) or an immunogenic fragment thereof to the animal; vaccines |
| 05/02/2002 | US20020051790 Helicobacter pylori; antigen of given amino acid sequences; superoxide dismutase in the form of a vaccine |
| 05/02/2002 | US20020051784 Methods for modulating T cell unresponsiveness |
| 05/02/2002 | US20020051783 Method for producing or enhancing a T-cell response against a target cell using a complex comprising an HLA class I molecule and an attaching means |
| 05/02/2002 | US20020051770 Virus neutralizing level of antibodies |
| 05/02/2002 | US20020051769 Gene delivery vectors and their uses |
| 05/02/2002 | US20020051768 Encapsidated recombinant poliovirus nucleic acid and methods of making and using same |
| 05/02/2002 | US20020051765 Method of cancer treatment |
| 05/02/2002 | US20020051751 Therapy using the Mossbauer absorption phenomenon; pharmaceuticals containing radiation absorber isotope are administered and then excited; results in radiolysis of DNA resulting in lethal breaks in DNA molecules of target tissue |
| 05/02/2002 | EP1201761A1 Method of constructing recombinant adenovirus vector |
| 05/02/2002 | EP1201760A1 Influenza virus vector for human dendritic cells |
| 05/02/2002 | EP1201757A2 Method for preparing water soluble polypeptides |
| 05/02/2002 | EP1201756A2 Method for preparing water soluble polypeptides |
| 05/02/2002 | EP1201755A1 Gene of human brain type pgt |
| 05/02/2002 | EP1201754A1 Apoptosis-associated factor |
| 05/02/2002 | EP1201681A1 "Fail" molecules and uses thereof |
| 05/02/2002 | EP1201680A2 Tumor suppressor polypeptide issued from CHC1-L (chromosome condensation 1-like) |
| 05/02/2002 | EP1201679A2 Angiotensin I-converting enzyme inhibitory substance |
| 05/02/2002 | EP1201676A2 PNA-DNA-PNA chimeric macromolecules |
| 05/02/2002 | EP1201246A2 Use of thrombopoietin as a medicament for the therapy and prevention of thrombocytopenia |
| 05/02/2002 | EP1200835A1 Methods for identification of compounds stimulating insulin secretion |
| 05/02/2002 | EP1200622A1 Adenovirus carrying gag gene hiv vaccine |
| 05/02/2002 | EP1200617A2 Methods for conditional transgene expression and trait removal in plants |
| 05/02/2002 | EP1200616A2 Enhanced delivery via serpin enzyme complex receptor ligands |
| 05/02/2002 | EP1200614A1 Herbicide resistant transgenic plants with mutated alpha-tubulin |
| 05/02/2002 | EP1200612A2 Dna encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5a, transgenic plants and a method for controlling senescence and programmed cell death in plants |
| 05/02/2002 | EP1200610A1 Gene controlling shoot branching in plants |
| 05/02/2002 | EP1200608A2 Chimeric polypeptides of serum albumin and uses related thereto |
| 05/02/2002 | EP1200607A2 Tet repressor-based transcriptional regulatory proteins |
| 05/02/2002 | EP1200603A1 Production of proteins by autoproteolytic cleavage |
| 05/02/2002 | EP1200595A2 Myxoma virus genes for immune modulation |
| 05/02/2002 | EP1200594A2 Protective antigen of epstein barr virus |
| 05/02/2002 | EP1200593A2 The il-1l1 gene and polypeptide products |
| 05/02/2002 | EP1200592A2 Mammalian cytokines; related reagents |
| 05/02/2002 | EP1200591A1 Human homologue of bovine neuroendocrine secretory protein, nesp55, polynucleotides and uses thereof linked with obesity |
| 05/02/2002 | EP1200590A1 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| 05/02/2002 | EP1200589A1 Modified ciliary neurotrophic factor, method of making and methods of use thereof |
| 05/02/2002 | EP1200588A1 Single-chain polypeptides comprising troponin i n-terminal fragments and troponin c |
| 05/02/2002 | EP1200587A2 Receptors and associated proteins |
| 05/02/2002 | EP1200586A2 Human nervous system-associated proteins |
| 05/02/2002 | EP1200585A1 T-cell receptor gamma alternate reading frame protein, (tarp) and uses thereof |
| 05/02/2002 | EP1200584A1 Splice variants of cd40-receptor |
| 05/02/2002 | EP1200583A2 Fabrication of beta-pleated sheet proteins with specific binding properties |
| 05/02/2002 | EP1200582A2 Human proteins having hydrophobic domains and dnas encoding these proteins |
| 05/02/2002 | EP1200581A1 Truncated egf receptor |
| 05/02/2002 | EP1200576A2 Dna's encoding proteins with signal peptides |
| 05/02/2002 | EP1200575A1 Inducible cancer model to study the molecular basis of host tumor cell interactions in vivo |
| 05/02/2002 | EP1200571A1 Secretory molecules |
| 05/02/2002 | EP1200568A2 Purine metabolism genes in plants |
| 05/02/2002 | EP1200563A1 Attenuated influenza virus useful as vaccine |
| 05/02/2002 | EP1200561A1 Recombinant stabile cell clone, its production and use thereof |
| 05/02/2002 | EP1200560A1 Melanin-concentrating hormone receptor |
| 05/02/2002 | EP1200479A1 Multiple cytokine-antibody complexes |
| 05/02/2002 | EP1200477A1 Prognosis and therapy of malignant diseases by antibodies which bind phosphorylated met protein |
| 05/02/2002 | EP1200476A1 Antitumor antibodies, proteins, and uses thereof |
| 05/02/2002 | EP1200474A1 Human g-protein coupled receptor |
| 05/02/2002 | EP1200473A1 Receptor |
| 05/02/2002 | EP1200472A1 Odorant receptors |
| 05/02/2002 | EP1200471A1 Method for purifying granulocyte colony stimulating factor |
| 05/02/2002 | EP1200470A2 Globular assembly of amyloid beta protein and uses thereof |
| 05/02/2002 | EP1200469A2 Fragments of cellular prion protein and methods useful in the diagnosis and treatment of prion diseases |
| 05/02/2002 | EP1200468A1 CRYSTALLIZATION AND STRUCTURE DETERMINATION OF i STAPHYLOCOCCUS AUREUS /i ELONGATION FACTOR P |
| 05/02/2002 | EP1200467A1 Novel human calcium sensitive potassium channel subunits |
| 05/02/2002 | EP1200466A2 Tuberculosis vaccine and diagnostics based on the mycobacterium tuberculosisesat-6 gene family |
| 05/02/2002 | EP1200465A1 Antigenic epitopes and mosaic polypeptides of hepatitis c virus proteins |
| 05/02/2002 | EP1200464A2 Synthetic peptides immunoreactive with hepatitis a virus antibodies |
| 05/02/2002 | EP1200463A2 Antimicrobial histone h1 compositions, kits, and methods of use thereof |
| 05/02/2002 | EP1200462A2 Use of quinic, shikimic acids and their derivatives for preparing mannose receptor ligands |
| 05/02/2002 | EP1200461A2 Polypeptide dendrimers as unimolecular carriers of diagnostic imaging contrast agents, bioactive substances and drugs |
| 05/02/2002 | EP1200459A1 Compounds for treatment of infectious and immune system disorders and methods for their use |
| 05/02/2002 | EP1200458A1 Uses of peptides derived from the cytoplasmic domain of the amyloid protein precursor (app) |
| 05/02/2002 | EP1200132A2 Nucleic acid and amino acid sequences of infectious salmon anaemia virus and their use as vaccines |
| 05/02/2002 | EP1200125A1 Psca: prostate stem cell antigen and uses thereof |
| 05/02/2002 | EP1200124A1 Immunoglobulin fusion proteins |
| 05/02/2002 | EP1200120A1 Pneumococcal vaccines |
| 05/02/2002 | EP1200119A2 Method for down-regulating gdf-8 activity |
| 05/02/2002 | EP1200116A2 USE OF FVIIa OR A TISSUE FACTOR ANTAGONIST FOR REGULATING GENE EXPRESSION AND CELL MIGRATION OR CHEMOTAXIS |
| 05/02/2002 | EP1200113A2 Reagents and methods useful for detecting diseases of the prostate |
| 05/02/2002 | EP1200112A2 Chemokine binding protein of gammaherpesvirus 68 and methods of use therefor |
| 05/02/2002 | EP1200109A1 Inducing cellular immune responses to hepatitis c virus using peptide and nucleic acid compositions |
| 05/02/2002 | EP1200105A1 Modified factor viii |
| 05/02/2002 | EP1080191A4 Insect control gene dsf and methods of use |
| 05/02/2002 | EP0929694A4 Detection of extracellular tumor-associated nucleic acid in blood plasma or serum using nucleic acid amplification assays |
| 05/02/2002 | EP0859854B1 Retroviral vectors carrying senescent cell derived inhibitors 1 (sdi-1) or antisense sdi-1 nucleotide sequences |
| 05/02/2002 | EP0801744B1 Peptide reagent for detecting a primary epstein-barr virus infection by testing for the corresponding antibodies, and method for using same |
| 05/02/2002 | EP0739420B1 Primers for the amplification of genes coding for the enterotoxin and the lecithinase of clostridium perfringens and their application to the detection and counting of these bacteriae |
| 05/02/2002 | EP0724884B1 Side effect inhibitor for cancer therapy |
| 05/02/2002 | EP0593585B1 Peptide which abrogates tnf and lps toxicity |
| 05/02/2002 | EP0573500B2 Fused genes and their use for determining the presence of metals or of xenobiotic compounds |
| 05/02/2002 | EP0455665B1 Hybrid seed production |